HCP5 and metastatic malignant neoplasm in the lymph nodes: Only one study [15] reported that HCP5 function as the tumor suppressor in skin cutaneous melanoma, down-regulation of HCP5 was associated with a poor OS (HR = 2.97, 95% CI 1.64–5.36), advanced tumor stage, positive distal metastasis and lymph node metastasis.